Publication | Open Access

Decreased resistance to gemcitabine (2′,2′-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase

Altered ActivityMolecular PharmacologyHematological MalignancyDeoxycytidine KinaseMedicineSubstrate SpecificityMyeloid NeoplasiaCancer Cell BiologyAnti-cancer AgentCellular BiochemistryPharmacologyCell BiologyCancer ResearchTumor BiologyDrug Resistance